<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000662458">
  <TermName>COPP</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin and non-Hodgkin lymphomas. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called COPP regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000734714" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPP&quot;" language="en" id="_3"/>
  <SpanishTermName>COPP</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento de linfomas de Hodgkin y no Hodgkin. Incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama régimen COPP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-04-23</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000686548" url="/about-cancer/treatment/drugs/COPP">COPP</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
